Related Experiment Video
Updated: Jul 4, 2026

Models of Bone Metastasis
Published on: September 4, 2012
An analysis of the incidence of myocardial metastasis from solid cancers
1Department of Experimental Pathology, Roswell Park Cancer Institute, Buffalo, NY 14263.
Abstract:
Metastasis to the heart is compared with that to other target sites in terms of incidence, tissue susceptibility, and cancer cell injury within the microcirculation. At necropsy the myocardium is the sixth most common site for arterial metastasis among eight target organs in ten different types of disseminated primary cancer. However, the metastatic efficiency index (incidence/blood flow) indicates that the myocardium is no less susceptible to metastasic per unit of cancer cells delivered than most other sites examined. The analyses also indicate that cancer cells causing myocardial metastasis are mainly derived from metastatic or primary tumours in the lungs. Experiments on laboratory animals suggest that the failure to develop myocardial metastasis in 80 to 98% of patients with metastatic cancer is at least partially due to lethal, deformation-associated, mechanical damage inflicted on cancer cells trapped within the myocardial microvasculature.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

